Looking Ahead in MedTech Policy: Part 2
Mar 03, 2022•33 min•Ep. 13
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Market Pathways editors Steve Levin and David Filmore discuss important medtech regulatory and policy developments they are looking for in 2022. In this second of a two-part conversation, they delve into the EU picture, including the MDR, IVDR, and other oncoming regulatory challenges. Steve and Dave also talk about the very active regulatory reform efforts in China and the rest of Asia.
Read more about the topics discussed in this episode:
MDR Is Here: Now What Does It Mean? The Future of European Device Regulation Is Closer Than You Think: What Comes After MDR? New Chinese Medtech Regs Offer New OpportunitiesFor the best experience, listen in Metacast app for iOS or Android